Nicotine Mini Lozenge
Product Images NDC 59726-262

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Nicotine Mini (NDC 59726-262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by P & L Development, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nicotine Polacrilex 2 mg (Nicotine 2 mg Mint Lozenge 1)

This is a description of a nicotine lozenge product called DrugFacts. It contains 2 mg of nicotine polacrilex and helps in quitting smoking. The lozenges are available in 135 pieces with 5 vials of 27 pieces each. The user should use at least 8 lozenges a day for 12 weeks along with a support program as directed in the user's guide. The product is not for sale for those under 18 years of age, and proof of age is required. For those who smoke their first cigarette over 30 minutes after waking up, 2 mg of the lozenge is recommended, and for those who smoke within 30 minutes after waking, 4 mg lozenges are recommended. The product is manufactured and distributed by PL Developments, and for further details, one can visit the website sixthehabit.com.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.